|
|
Article: Vanderbilt-Ingram Cancer Center Signs on with Open Biosystems' Open Access(TM) Program for Breast Cancer Research; Leading Cancer Centers Continue to Recognize the Value of shRNAmir and cDNA Technology.
- Article from:
- Business Wire
- Article date:
- September 11, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HUNTSVILLE, Ala. -- Open Biosystems, Inc., focused on the commercialization of leading-edge life science research tools for drug discovery, today announced that Vanderbilt-Ingram Cancer Center, a recognized leader in cancer prevention, care and research, has joined its Open Access Program for RNAi and cDNA resources.
The Open Access RNAi Program provides the Cancer Center with access to Open Biosystems' whole-genome lentiviral human and mouse shRNAmir libraries for RNAi as well as the Mammalian Gene Collection (MGC) complementary DNA (cDNA) collection. Currently, Vanderbilt-Ingram is utilizing these tools to advance research efforts that may lead to ...